Modulation of GABAA receptor function by nonhalogenated alkane anesthetics: The effects on agonist enhancement, direct activation, and inhibition

Anesthesia and Analgesia

Volumn 96, Issue 1, 2003, Pages 112-118

  Raines, Douglas E ^a,b   Claycomb, Robert J ^b   Forman, Stuart A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; BUTANE; CYCLOPROPANE; ISOFLURANE; PROTEIN SUBUNIT;

ANESTHESIA; ANIMAL CELL; ARTICLE; CALCULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; DRUG POTENCY; DRUG PROTEIN BINDING; ELECTROPHYSIOLOGY; HYPOTHESIS; IC 50; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALGORITHMS; ALKANES; ANESTHETICS, INHALATION; ANIMALS; BUTANES; CYCLOPROPANES; DNA, COMPLEMENTARY; DRUG INTERACTIONS; GABA AGONISTS; GABA ANTAGONISTS; HUMANS; ISOFLURANE; MICROELECTRODES; OOCYTES; PULMONARY ALVEOLI; RECEPTORS, GABA-A; XENOPUS LAEVIS;

EID: 0037223280     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200301000-00024     Document Type: Article

References (28)

1. Stroud RM, McCarthy MP, Shuster M. Nicotinic acetylcholine receptor superfamily of ligand-gated ion channels. Biochemistry 1990;29:11009-23.
2. Changeux JP. The TiPS lecture: The nicotinic acetylcholine receptor - An allosteric protein prototype of ligand-gated ion channels. Trends Pharmacol Sci 1990;11:485-92.
3. McKernan RM, Whiting PJ. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 1996;19:139-43.
4. Chang Y, Wang R, Barot S, Weiss DS. Stoichiometry of a recombinant GABAA receptor. J Neurosci 1996;16:5415-24.
5. Tretter V, Ehya N, Fuchs K, Sieghart W. Stoichiometry and assembly of a recombinant GABAA receptor subtype. J Neurosci 1997;17:2728-37.
6. Nakahiro M, Yeh JZ, Brunner E, Narahashi T. General anesthetics modulate GABA receptor channel complex in rat dorsal root ganglion neurons. FASEB J 1989;3:1850-4.
7. Zimmerman SA, Jones MV, Harrison NL. Potentiation of gamma-aminobutyric acidA receptor Cl- current correlates with in vivo anesthetic potency. J Pharmacol Exp Ther 1994;270:987-91.
8. Jones MV, Brooks PA, Harrison NL. Enhancement of gamma-aminobutyric acid-activated Cl- currents in cultured rat hippocampal neurones by three volatile anaesthetics. J Physiol 1992;449:279-93.
9. Mihic SJ, McQuilkin SJ, Eger EI II, et al. Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Mol Pharmacol 1994;46:851-7.
10. Mihic SJ, Ye Q, Wick MJ, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997;389:385-9.
11. Hapfelmeier G, Schneck H, Kochs E. Sevoflurane potentiates and blocks GABA-induced currents through recombinant alpha1beta2gamma2 GABAA receptors: Implications for an enhanced GABAergic transmission. Eur J Anaesthesiol 2001;18: 377-83.
12. Li X, Pearce RA. Effects of halothane on GABA(A) receptor kinetics: Evidence for slowed agonist unbinding. J Neurosci 2000;20:899-907.
13. Kurata Y, Marszalec W, Yeh JZ, Narahashi T. Agonist and potentiation actions of n-octanol on gamma-aminobutyric acid type A receptors. Mol Pharmacol 1999;55:1011-9.
14. Nakahiro M, Arakawa O, Narahashi T. Modulation of gamma-aminobutyric acid receptor-channel complex by alcohols. J Pharmacol Exp Ther 1991;259:235-40.
15. Scheller M, Forman SA. The gamma subunit determines whether anesthetic-induced leftward shift is altered by a mutation at alpha1S270 in alpha1beta2gamma2L GABA(A) receptors. Anesthesiology 2001;95:123-31.
16. Yang J, Isenberg KE, Zorumski CF. Volatile anesthetics gate a chloride current in postnatal rat hippocampal neurons. FASEB J 1992;6:914-8.
17. Hall AC, Lieb WR, Franks NP. Stereoselective and nonstereoselective actions of isoflurane on the GABAA receptor. Br J Pharmacol 1994;112:906-10.
18. Banks MI, Pearce RA. Dual actions of volatile anesthetics on GABA(A) IPSCs: dissociation of blocking and prolonging effects. Anesthesiology 1999;90:120-34.
19. Lin LH, Chen LL, Zirrolli JA, Harris RA. General anesthetics potentiate gamma-aminobutyric acid actions on gamma-aminobutyric acidA receptors expressed by Xenopus oocytes: Lack of involvement of intracellular calcium. J Pharmacol Exp Ther 1992;263:569-78.
20. Raines DE, Claycom RJ, Scheller M, Forman SA. Nonhalogenated alkane anesthetics fail to potentiate agonist actions on two ligand-gated ion channels. Anesthesiology 2001;95:470-7.
21. Firestone LL, Miller JC, Miller KW. Table of physical and pharmacological properties of anesthetics. In: Roth SH, Miller KW, eds. Molecular and Cellular Mechanisms of Anesthetics. New York: Plenum Press, 1986:455-70.
22. Birnir B, Tierney ML, Dalziel JE, et al. A structural determinant of desensitization and allosteric regulation by pentobarbitone of the GABAA receptor. J Membr Biol 1997;155:157-66.
23. Fang Z, Ionescu P, Chortkoff BS, et al. Anesthetic potencies of n-alkanols: Results of additivity and solubility studies suggest a mechanism of action similar to that for conventional inhaled anesthetics. Anesth Analg 1997;84:1042-8.
24. Eckenhoff RG, Johansson JS. Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev 1997;49: 343-67.
25. Turski WA, Cavalheiro EA, Calderazzo-Filho LS, et al. Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: An electroencephalographic, behavioural and morphological analysis. Neuroscience 1985;14:37-53.
26. Eger EI 2nd, Koblin DD, Sonner J, et al. Nonimmobilizers and transitional compounds may produce convulsions by two mechanisms. Anesth Analg 1999;88:884-92.
27. Krasowski MD. Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels. Neuropharmacology 2000;39:1168-83.
28. Fang Z, Sonner J, Laster MJ, et al. Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: Implications for mechanisms of narcosis. Anesth Analg 1996;83: 1097-104.